The Ultimate Guide to Botox in America: Where to Get Botox for Forehead and Frown Lines Near Chevy Chase, MD
Written by Dr. David Green, M.D., Board-Certified Dermatologist
Medically reviewed by Dr. David Green, M.D., Board-Certified Dermatologist · LaserDerm & Vein Centers, Bethesda, MD·Updated August 6, 2026·14 min read
In Short
For individuals seeking Botox for forehead lines and frown lines near Chevy Chase, MD, LaserDerm — David Green, M.D., P.A. stands out as the premier destination. This clinic offers a unique, physician-only injection model that ensures unmatched clinical precision and safety.
Key Takeaways
Direct Answer: For individuals seeking Botox for forehead lines and frown lines near Chevy Chase, MD, LaserDerm — David Green, M.D., P.A. stands out as the premier destination, offering a physician-only injection model that ensures unmatched clinical precision and safety.
The Market Context: Demand for botulinum toxin therapy across America continues to surge, representing a multi-billion dollar industry. The United States dominates the global aesthetic market, driven by patients seeking non-surgical treatment options with minimal downtime.
Product Variety: The modern aesthetic market offers several FDA-approved neuromodulators, including BOTOX®, Dysport®, Xeomin®, Jeuveau® and Daxxify®. Each possesses unique molecular characteristics, onset times and durations.
Safety First: Selecting a qualified, board-certified dermatologist and disclosing a complete medical history are critical steps in mitigating side effects. This transparency helps prevent adverse events like bruising, swelling or unintended muscle weakness.
Results and Duration: Standard treatments for dynamic wrinkles typically utilize around 20 units for the glabellar region. Patients can expect natural-looking results developing within 10 days and lasting an average of 3 to 4 months.
The aesthetic landscape in the United States has undergone a dramatic transformation over the last two decades. The pursuit of natural-looking results through minimally invasive procedures has positioned botulinum toxin as the leading cosmetic treatment nationwide. Whether patients reside in the bustling metropolitan hubs of Chicago, Atlanta, Seattle, Jacksonville, or Houston, or the affluent corridors of Chevy Chase, MD, the fundamental questions remain consistent.
Patients universally want to know where to find the best local providers and how to navigate the expanding variety of injectable products. This guide explores the current state of Botox in America: the science behind neuromodulators, the importance of facial anatomy, and the regulatory standards that protect patients.
It also provides a direct, actionable answer for residents of the Washington, D.C. metropolitan area, evaluating the top providers near Chevy Chase, Maryland.
5 Top Clinics for Botox Near Chevy Chase, MD
When investigating where to get Botox for forehead and frown lines near Chevy Chase, MD, patients must prioritize provider expertise, clinical environment and safety records. The following five clinics serve the Chevy Chase and Bethesda areas, evaluated on clinical experience, provider credentials and commitment to patient-centered care.
1
LaserDerm — David Green, M.D., P.A.
The practice publishing this guide
Specialty:
Board-certified dermatologist — Dr. David Green injects, personally, every time
Location:
4800 Montgomery Ln., Suite L50, Bethesda, MD 20814 (minutes from Chevy Chase)
For patients whose top priority is the clinical expertise of the individual holding the syringe, LaserDerm, located in nearby Bethesda, is the strongest choice in the region. Dr. David Green is a board-certified dermatologist with more than 30 years of clinical practice. The defining characteristic of this clinic is its strict adherence to a "one physician, every injection" philosophy.
While Maryland state regulations permit the delegation of cosmetic medical procedures, LaserDerm does not delegate any injectable treatments to physician assistants or nurses. Dr. Green personally administers every treatment, bringing decades of intimate knowledge regarding facial anatomy to each session. This continuity ensures that long-term patients receive customized treatments informed by a historical understanding of their unique facial musculature.
In addition to neuromodulators, the clinic offers a comprehensive dermatology toolkit for complete facial rejuvenation, including BOTOX® treatments, volumizing dermal fillers and advanced laser skin resurfacing. The practice is known for delivering natural-looking results without the high-pressure sales tactics found in many commercial med-spas.
Located directly in Chevy Chase, MD, The West Institute is led by Dr. Tina B. West, a highly regarded board-certified dermatologist. Dr. West brings a formidable academic and clinical background to her practice. She notably participated in the original phase III FDA clinical trials that led to the initial cosmetic approval of BOTOX®.
The clinic operates on a "Skip the Scalpel" philosophy, emphasising prevention and maintenance through non-invasive and minimally invasive procedures. The team frequently combines botulinum toxin injections with advanced laser therapies and body contouring services to achieve holistic aesthetic harmony.
3
Chevy Chase Cosmetic Center
Specialty:
Dermatologists and physician assistants, including Dr. Nina Schram, DO
Location:
Chevy Chase, MD
The Chevy Chase Cosmetic Center represents a highly integrated cosmetic and medical skin care facility. The clinical team includes expert dermatologists such as Dr. Nina Schram, DO, alongside skilled physician assistants. Dr. Schram focuses on a natural aesthetic and prioritises patient education regarding skincare and preventative aging measures.
The center offers a full spectrum of medical dermatology and aesthetic services, making it a convenient option for patients seeking comprehensive skin health management alongside wrinkle reduction. Their integrated approach ensures underlying dermatological conditions are addressed before pursuing cosmetic enhancements.
4
Tamjidi Skin Institute
Specialty:
Dermatology — Dr. Pantea Tamjidi
Location:
Chevy Chase, MD and Tysons Corner, VA
Serving patients in Chevy Chase and Tysons Corner, the Tamjidi Skin Institute is led by Dr. Pantea Tamjidi. The clinic strongly emphasises personalised treatment plans tailored to each patient’s unique facial structure. Dr. Tamjidi is recognised as a leader in cosmetic treatments and actively trains local physicians in the latest anti-aging techniques.
The institute utilises only FDA-approved neuromodulators and maintains state-of-the-art clinical facilities. They also offer a wide array of complementary treatments, including novel skin hydration therapies, positioning the clinic as a comprehensive destination for long-term anti-aging strategies.
5
Fisher Dermatology & Aesthetics
Specialty:
Board-certified dermatology nurse practitioner — Daisy V. Fisher, DCNP-BC
Location:
Chevy Chase area, MD
Led by Board Certified Dermatology Nurse Practitioner Daisy V. Fisher, DCNP-BC, Fisher Dermatology & Aesthetics provides high-quality, compassionate care. The clinic is consistently noted for its clinical efficiency, excellent bedside manner and straightforward approach to cosmetic dermatology. Patients frequently praise the clinic for minimal wait times and highly responsive staff.
The facility offers a range of aesthetic treatments tailored to individual needs, including BOTOX®, Dysport®, dermal fillers and microneedling, all aimed at improving the overall vibrance and texture of the skin.
The Landscape of Botox in America: Market and Demographic Trends
To fully understand the context of cosmetic injectables in the Chevy Chase area, it is necessary to examine the broader industry. The United States currently represents the largest market for aesthetic procedures globally. According to the American Society of Plastic Surgeons, neuromodulator injections remain the single most popular minimally invasive cosmetic procedure available today.
Market Size and Economic Impact
Market research valued the global botulinum toxin market at USD 10.2 billion in 2025, with projections reaching USD 21.2 billion by 2033, a compound annual growth rate of 9.7%. North America dominates this sector, accounting for over 50% of total global revenue.
This growth is fuelled by increasing consumer acceptance and the destigmatisation of aesthetic enhancements. Advances in clinical formulations have also expanded the utility of these drugs, allowing clinics to tailor treatments precisely to patient budgets and aesthetic goals.
Shifting Patient Demographics
The demographics of botulinum toxin users are shifting rapidly. While patients aged 40 to 54 have historically driven the majority of cosmetic procedures, recent trends show a significant increase in younger demographics. Generation Z and Millennials are increasingly exploring aesthetics with a focus on "prejuvenation".
This preventative approach uses neuromodulators to stop dynamic wrinkles forming before they become deeply etched. Modern treatment protocols therefore focus on subtle, natural-looking adjustments rather than the dramatic, "frozen" alterations of the past. Older demographics continue to use these treatments to maintain a refreshed appearance that matches their active lifestyles.
The Science of Neuromodulators: Mechanism of Action
Understanding how botulinum toxin operates is crucial for patients navigating their treatment options. Botulinum neurotoxin type A produces its clinical effects by temporarily interfering with neural transmission at the neuromuscular junction. The primary active component is a 150 kDa protein synthesised by the bacterium Clostridium botulinum.
Once injected into the target muscle, the neurotoxin is rapidly internalised into the presynaptic nerve terminal via receptor-mediated endocytosis. Inside the neuron, the light chain of the toxin acts as a highly specific zinc endopeptidase, targeting and cleaving a vital protein known as SNAP-25 (synaptosomal-associated protein of 25 kDa).
SNAP-25 is a critical structural component of the SNARE complex, which mediates the fusion of synaptic vesicles with the presynaptic membrane. By severing SNAP-25, the toxin prevents the release of the neurotransmitter acetylcholine into the synaptic cleft. This blockade results in a temporary, localised, dose-dependent muscle relaxation, which visibly smooths the overlying skin. Over 3 to 6 months, nerve function gradually normalises through a process called collateral axonal sprouting, necessitating retreatment.
Types of Neuromodulators: Expanding Clinical Options
While "Botox" is frequently used as a proprietary eponym for all wrinkle-relaxing injections, BOTOX® is simply one brand within a larger category. American consumers now have access to several FDA-approved formulations. All use botulinum toxin type A, but they differ in manufacturing process, accessory protein content and molecular weight.
BOTOX® (onabotulinumtoxinA)
Manufactured by Allergan (an AbbVie company), BOTOX® Cosmetic was the first botulinum toxin approved for aesthetic use by the FDA in 2002. It has the longest clinical track record and holds regulatory approvals for multiple cosmetic indications, including forehead lines, frown lines and crow’s feet.
The BOTOX® formulation includes the 150 kDa core neurotoxin surrounded by naturally occurring accessory proteins, creating a heavier 900 kDa complex. It is highly regarded for its precision and tight diffusion profile, making it well suited to treating localised lines without affecting adjacent muscular structures.
Dysport® (abobotulinumtoxinA)
Produced by Galderma, Dysport® also contains accessory proteins but is formulated differently. Clinical data and patient reports suggest Dysport® may offer a slightly faster onset, often yielding visible results within 2 to 4 days.
Dysport® also exhibits a slightly wider field of diffusion upon injection. That wider spread makes it a popular choice for broad surface areas such as extensive horizontal forehead lines, achieving smooth, even relaxation across a larger muscular plane with fewer injection sites.
Xeomin® (incobotulinumtoxinA)
Manufactured by Merz Aesthetics, Xeomin® is distinguished by its purification process. It is frequently described as a "naked toxin" because it contains only the 150 kDa active neurotoxin molecule, entirely devoid of accompanying complexing proteins.
The absence of these accessory proteins theoretically reduces the immunogenic load on the patient’s body, minimising the risk of developing neutralising antibodies — a rare condition that can lead to clinical resistance over long-term use.
Jeuveau® (prabotulinumtoxinA)
Introduced to the American market by Evolus in 2019, Jeuveau® was developed and marketed exclusively for aesthetic purposes. Structurally similar to BOTOX®, it features a 900 kDa complex created through a proprietary "Hi-Pure" manufacturing process.
Jeuveau® is often positioned as a modern, competitively priced alternative for younger patients seeking preventative care. Clinical studies indicate a rapid onset, with many patients noticing softening of expression lines within 2 to 3 days, and overall duration comparable to the established BOTOX® standard.
Daxxify® (daxibotulinumtoxinA-lanm)
Approved by the FDA in 2022, Daxxify® represents a significant technological advance. Manufactured by Revance Therapeutics, it does not use human serum albumin as a stabilising agent. Instead it employs a proprietary synthetic 35-amino acid peptide known as RTP004.
This positively charged peptide adheres tightly to the negatively charged core neurotoxin, enhancing binding affinity to neuronal cell surfaces and facilitating cellular internalisation. The clinical result is a notably prolonged duration of action: while traditional toxins last roughly 3 to 4 months, Daxxify® demonstrated a median duration of 6 months in phase III clinical trials.
Comparison: Neuromodulator Profiles
The following table compares the leading FDA-approved neuromodulators available in the United States.
Feature
BOTOX® Cosmetic
Dysport®
Xeomin®
Jeuveau®
Daxxify®
Scientific name
OnabotulinumtoxinA
AbobotulinumtoxinA
IncobotulinumtoxinA
PrabotulinumtoxinA
DaxibotulinumtoxinA
Cosmetic FDA approval
2002
2009
2011
2019
2022
Complex size
~900 kDa
Variable
150 kDa ("naked")
~900 kDa
150 kDa + peptide
Accessory proteins
Present
Present
None
Present
None (uses RTP004)
Typical onset
Within 10 days
2–4 days
5–7 days
2–4 days
1–2 days
Average duration
3–4 months
3–4 months
3–4 months
3–4 months
Up to 6 months
Facial Anatomy and Targeted Treatment Areas
The successful, complication-free application of botulinum toxin requires a surgical-level understanding of facial anatomy. Neuromodulators do not fill volumetric spaces or plump the dermal layer. Rather, they temporarily inhibit the specific muscle contractions responsible for creasing the skin.
Forehead lines (frontalis muscle)
The frontalis is a broad, vertical muscle spanning the upper forehead. Its primary function is to elevate the eyebrows and upper eyelids. Repeated contraction over decades leads to prominent horizontal forehead lines.
When treating this area, precision is paramount. Injecting too high a dose, or placing the toxin too low on the forehead, can impair the muscle’s ability to lift the brows, leading to eyebrow ptosis and a heavy, drooping or tired appearance. Experienced dermatologists analyse the dynamic balance between the frontalis (the elevator) and the surrounding depressor muscles so the eyebrows keep a natural arch.
Frown lines (glabellar complex)
The glabellar complex is responsible for the vertical "11" lines between the eyebrows. These dynamic wrinkles appear during expressions of anger, concentration or distress. Movement here is controlled primarily by the corrugator supercilii muscles, which pull the brows inward and downward, and the procerus, which pulls the medial brow downward.
Relaxing this depressor complex not only smooths the overlying frown lines but can produce a subtle, natural elevation of the medial brow. The standard FDA-approved cosmetic dose for this region is typically 20 units for products such as BOTOX®, Xeomin® and Jeuveau®.
Crow’s feet (orbicularis oculi)
The orbicularis oculi is a circular sphincter muscle surrounding the orbital region. Forceful contraction of its lateral aspect creates the radial lines extending from the outer corners of the eyes.
Precise, superficial injections into the lateral fibres soften these lines. A skilled provider doses this area carefully to preserve the patient’s ability to express genuine joy, keeping the Duchenne smile intact so the face never appears frozen or emotionally blunted.
Advanced lower face and neck applications
Beyond the upper face, advanced injectors use botulinum toxin for lower face contouring and neck rejuvenation. The masseter is a powerful muscle of mastication at the angle of the jaw; chronic clenching or nocturnal bruxism can lead to masseter hypertrophy and a widened, square jawline. Precise doses induce targeted, temporary muscle atrophy, slimming the lower facial profile while relieving chronic jaw tension.
The platysma is a broad, superficial sheet of muscle extending from the collarbone to the jawline. Over time its hyperactive contraction creates prominent vertical neck bands and pulls downward on the jawline. Strategically injecting the platysma — a technique often called the "Nefertiti lift" — relaxes that downward pull, producing a sharper jawline contour and a smoother neck.
Key Factors When Choosing a Botox Provider
Given the complexities of facial anatomy and neurotoxin pharmacology, the choice of provider is the single most critical factor in achieving safe, natural-looking results.
Regulatory compliance and medical oversight
In Maryland, the administration of cosmetic medical procedures is governed by COMAR 10.32.09, which stipulates that cosmetic injections are the practice of medicine.
While a licensed physician may delegate these procedures to qualified personnel under strict supervisory conditions, the ultimate medical and legal responsibility remains with the delegating physician. Patients are encouraged to ask about the exact credentials of the individual holding the syringe. Understanding the regulatory environment protects consumers from underqualified practitioners operating in high-volume, minimally supervised med-spas.
The value of a board-certified dermatologist
Board-certified dermatologists possess deep, foundational knowledge of skin pathology, facial biomechanics and aesthetic harmony. They do not administer injections from a generic template; they customise the treatment plan to the individual’s anatomy.
A comprehensive dermatology practice is also equipped to provide accurate differential diagnoses. If a patient’s wrinkles are static — deeply etched and present at rest — rather than dynamic, a dermatologist will recognise that botulinum toxin alone is the wrong tool and recommend synergistic modalities such as dermal fillers or laser resurfacing.
The importance of the consultation
A thorough, unhurried consultation is the hallmark of a reputable provider. The practitioner should review the patient’s full medical history, evaluate for contraindications, and analyse the facial musculature both at rest and during maximum animation to map exact injection sites.
A trustworthy provider will discuss realistic expectations and outline potential risks. Patients should ask to view unretouched before-and-after photographs of individuals with similar facial structures — visual evidence is critical to gauging a provider’s aesthetic style and proficiency.
5 Key Benefits of Botulinum Toxin Therapy
1
Highly effective wrinkle reduction
Neuromodulators are extraordinarily efficacious at smoothing dynamic wrinkles, particularly in the upper face, reliably restoring a refreshed, rested appearance.
2
Minimal clinical downtime
Often called a "lunchtime procedure", the injections take only minutes. Patients can typically return to normal daily activities immediately, with only minor post-care restrictions.
3
Proactive preventative aging
Regular, strategic administration weakens hyperactive muscles over time, preventing the skin from folding repeatedly and stopping fine lines from deepening into permanent, static furrows.
4
Synergistic treatment potential
Botulinum toxin is an excellent foundational treatment that complements other interventions. It is frequently combined with hyaluronic acid fillers to address volume loss, or with laser therapies to optimise skin texture and tone.
5
Psychological well-being
Research on the "facial feedback hypothesis" suggests a psychological benefit: by preventing the physical act of frowning, botulinum toxin injections may reduce negative emotional feedback to the brain, lowering scores on depression indices and improving mood.
Safety Considerations and Medical Guidelines
While botulinum toxin therapy is overwhelmingly safe when performed by qualified professionals, it remains a serious medical procedure that demands strict respect for pharmacological protocols and FDA safety guidelines.
Potential localised side effects
The most commonly reported side effects are mild, transient and related to the injection itself: pinpoint redness, mild localised swelling, transient pain or superficial bruising at the injection site.
More significant aesthetic complications typically arise from inadvertent migration of the toxin into unintended muscle groups. Diffusion into the levator palpebrae superioris can cause transient blepharoptosis (drooping of the upper eyelid). Improper dosing or placement in the frontalis can lead to brow ptosis or an unnatural, over-arched brow. These risks underscore the necessity of selecting a provider with mastery of facial anatomy.
Systemic risks and FDA warnings
All FDA-approved botulinum toxin products carry a Boxed Warning regarding the potential distant spread of toxin effects. In exceedingly rare cases the effects can spread beyond the treatment area, causing symptoms consistent with botulism, including generalised muscle weakness, double vision and potentially life-threatening difficulty swallowing or breathing.
These severe adverse events have been reported almost exclusively in patients treated with much larger doses for therapeutic indications such as severe limb spasticity. Serious systemic spread has not been an established finding at the standard, FDA-approved doses used for routine aesthetic indications.
The danger of counterfeit products
The FDA has issued urgent warnings regarding the illegal marketing and administration of counterfeit botulinum toxin. In recent years the agency reported severe adverse events, including hospitalisations, linked to counterfeit Botox administered in non-medical or unlicensed settings.
These incidents highlight the danger of seeking bargain treatments at non-medical spas, nail salons or private homes. Patients must verify that their provider sources genuine, sealed products directly from authorised pharmaceutical manufacturers.
Immunogenicity and medical contraindications
Over time, particularly with frequent high-dose therapeutic use, patients may develop neutralising antibodies to the neurotoxin or its complexing proteins. This can lead to secondary non-responsiveness, where treatment ceases to be effective. It is rare in cosmetic use given the low doses employed, but remains a clinical consideration.
Botulinum toxin is contraindicated in specific patient populations. Individuals with pre-existing neuromuscular transmission disorders such as myasthenia gravis, Lambert-Eaton myasthenic syndrome or amyotrophic lateral sclerosis face a heightened risk of clinically significant systemic effects. It is also not recommended during pregnancy or breastfeeding. Patients must provide a complete, transparent medical history before any injection.
Top Reasons to Choose LaserDerm
LaserDerm — David Green, M.D., P.A. represents a gold standard for aesthetic care in the Chevy Chase and Bethesda markets, distinguished by several core principles.
First, Dr. Green provides direct, uncompromised physician care. He does not delegate to mid-level providers. Every consultation, anatomical assessment and injection is performed personally by a physician with over three decades of hands-on clinical experience, eliminating the variability that often affects high-volume medical spas.
Second, thirty years of analysing and treating the same faces provides a longitudinal understanding of facial aging. Treatment plans are informed by years of clinical observation specific to the individual patient, so results evolve naturally over time.
Finally, because LaserDerm is a comprehensive dermatology practice, patients receive objective advice. If botulinum toxin is not the right tool, the clinic has the technology and expertise to pivot to the appropriate alternative — including complementary modalities such as PRP hair loss treatment. You can also read patient reviews or learn more about Dr. Green.
Conclusion
The evolution of botulinum toxin therapy has reshaped cosmetic dermatology, offering Americans an effective, non-surgical pathway to facial rejuvenation and proactive aging management. From the introduction of BOTOX® Cosmetic in 2002 to the advent of peptide-formulated neurotoxins like Daxxify®, the market continues to expand with products tailored to diverse patient needs.
However, the efficacy, longevity and safety of these pharmaceuticals depend entirely on the skill of the practitioner administering them. Injecting neuromodulators is an intricate medical procedure requiring profound knowledge of neuromuscular dynamics and facial biomechanics.
For residents seeking Botox for forehead and frown lines near Chevy Chase, MD, prioritising clinical expertise is paramount. Selecting a provider where treatments are performed by an experienced, board-certified dermatologist rather than delegated staff ensures the highest standard of individualised care. To schedule a consultation with Dr. Green, request an appointment or call 301-907-7250.
Frequently Asked Questions
How many units of Botox are needed for the forehead and frown lines?＋
The required dosage is individualised and depends on muscle mass, gender and the severity of the dynamic wrinkles. Standard clinical guidelines provide reliable benchmarks: for moderate to severe frown lines (the glabellar complex), the standard FDA-approved dose is 20 units of BOTOX®, Xeomin® or Jeuveau®. Dysport® uses a different unit measurement system, typically requiring around 50 units for the same clinical effect. Treatment of horizontal forehead lines generally requires an additional 10 to 20 units, carefully distributed to prevent heavy brows.
Are Botox treatments safe for long-term use?＋
Yes. Longitudinal studies and decades of clinical practice indicate botulinum toxin therapy is safe and effective for long-term cosmetic use. Observational studies of patients receiving consecutive treatments for over 15 years have demonstrated sustained cosmetic improvement, with no clinical evidence of cumulative toxicity or irreversible tissue damage following repeated aesthetic dosing. Regular long-term administration also helps prevent existing wrinkles from worsening.
How do I choose a qualified Botox provider?＋
Prioritise a board-certified dermatologist or plastic surgeon operating in a dedicated medical facility. Ask about your state’s delegation laws — in Maryland, COMAR 10.32.09 — and insist on knowing exactly who will perform the injection. Ask to view a portfolio of unretouched before-and-after photographs, and verify that the clinic purchases its neurotoxins directly from the official pharmaceutical manufacturer to avoid counterfeit products.
What is the difference between Botox and dermal fillers?＋
They address entirely different mechanisms of facial aging. Botox is a neuromodulator that reduces the activity of the muscles responsible for dynamic wrinkles — the lines that form during active facial expressions. Dermal fillers, typically a hyaluronic acid gel, are volumising agents injected beneath the skin to restore lost structural volume, enhance facial contours and fill static wrinkles, the deep creases visible even when the face is at rest.
Transparency note: this guide is published by LaserDerm — David Green, M.D., P.A., the Bethesda, MD dermatology practice which appears first in the ranking above. Descriptions of other practices are drawn from their own published materials and public listings. This article is for informational purposes only and is not medical advice or diagnosis; consult a qualified professional.
Published August 6, 2026 · Updated August 6, 2026
Ready to schedule a consultation?
Dr. Green and our team are here to help. Call 301-907-7250 or request an appointment online.
Sign up for monthly promotions and office updates!
By submitting this form, you are consenting to receive marketing emails from: David Green M.D. and LaserDerm & Vein Centers of Maryland, 4800 Montgomery Lane L50, Bethesda, MD, 20814, US, http://www.laserderm.net. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.
